SCHEMBL13338676

SCHEMBL13338676

CC(C)N(c1ccc(-c2ccccc2)cc1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 9/20 0.62
▸ BACE1 P56817 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ PSEN1 P49768 1/20 0.41
▸ PSEN2 P49810 1/20 0.41
▸ APH1B Q8WW43 1/20 0.41
▸ NCSTN Q92542 1/20 0.41
▸ APH1A Q96BI3 1/20 0.41
▸ PSENEN Q9NZ42 1/20 0.41
▸ MMP1 P03956 1/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ MMP3 P08254 1/20 0.40
▸ MMP7 P09237 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ CASR P41180 2/20 0.40
▸ GLO1 Q04760 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13338543 0.91 ALDH1A1 (0.48) KIF11ALDH1A1TSHRCYP3A4CYP2C19
SCHEMBL13338362 0.87 KIF11 (0.46) KIF11ALDH1A1TSHR
SCHEMBL11910685 0.85 PTGS2 (0.47) ALDH1A1
SCHEMBL18627702 0.84 PTGES (0.44) KIF11ALDH1A1
SCHEMBL13338533 0.84 PTGES (0.44) KIF11ALDH1A1
SCHEMBL18594383 0.83 ALDH1A1 (0.47) ALDH1A1
SCHEMBL13338406 0.83 ALDH1A1 (0.47) ALDH1A1
SCHEMBL13338501 0.80 KIF11 (0.41) KIF11ALDH1A1TSHR
SCHEMBL13338685 0.80 PTGS2 (0.40) ALDH1A1CYP2C19
SCHEMBL23059907 0.80 KIF11 (0.75) KIF11BACE1ALDH1A1TSHRGLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 KIF11 1027/4885BACE1 2841/4885ALDH1A1 428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback